Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following Rituximab treatment in systemic lupus erythematosus.
Autor: | Tew, G. W., Rabbee, N., Wolslegel, K., Hsieh, H.-J., Monroe, J. G., Behrens, T. W., Brunetta, P. G., Keir, M. E. keir.mary@gene.com |
---|---|
Zdroj: | Lupus. Feb2010, Vol. 19 Issue 2, p146-157. 12p. 3 Charts, 8 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |